Iteos Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Iteos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iteos Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Iteos Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $16M | 2.1M | 7.68 |
2024-09-30 | $4.8M | 467k | 10.21 |
2024-06-30 | $6.9M | 462k | 14.84 |
2024-03-31 | $242k | 18k | 13.64 |
2023-12-31 | $255k | 23k | 10.95 |
2023-09-30 | $260k | 24k | 10.95 |
2023-06-30 | $271k | 20k | 13.24 |
2023-03-31 | $6.9M | 496k | 13.96 |
2022-12-31 | $11M | 584k | 19.53 |
2022-06-30 | $12M | 559k | 20.61 |
2022-03-31 | $7.3M | 227k | 32.18 |
2021-12-31 | $2.7M | 59k | 46.65 |
2021-03-31 | $338k | 9.9k | 34.05 |
2020-12-31 | $171k | 5.0k | 33.87 |
2020-09-30 | $96k | 4.0k | 24.10 |